VO-659

N/A

Report date: 2024/11/26 14:38:28
NME

Base Information

Drug NameVO-659
Drug Alias NameVO-659
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProteins inhibitors
TargetsProteins
Therapy Area/IndicationsMachado-Joseph DiseaseSpinocerebellar AtaxiasHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsDenmarkGermany +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVico Therapeutics International
China Registration ClassN/A

Develop Information

Active CompaniesVico Therapeutics BV
Inactive CompaniesVico Therapeutics International
Active IndicationsMachado-Joseph DiseaseSpinocerebellar AtaxiasHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A